Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Lonza Group    LONN   CH0013841017

LONZA GROUP

(LONN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Carve-out of Lonza Specialty Ingredients will help segment to become a global leader in microbial control

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/03/2019 | 12:35am EDT

Carve-out of Lonza Specialty Ingredients will help segment to become a global leader in microbial control

  • Specialty Ingredients (LSI) will operate independently, but remain a fully owned segment of Lonza Group.
  • The carve-out will enable LSI to grow and strengthen its leading role in microbial control.
  • A focus on efficiency will place around 130 roles under consultation for redundancy in the LSI segment and Group-level support functions.

Basel, Switzerland, 3 June 2019 - Lonza Group today announced its intention to proceed with a carve-out of its Specialty Ingredients segment (LSI). The decision will see the LSI business under independent management, with increased control over its operations and costs. The segment will remain fully owned by Lonza. The company has already commenced with the separation and expects to complete the process by mid-year 2020.

Lonza Group CEO Marc Funk commented, "This is an important moment for our business and the LSI segment. Our decision will allow the segment to focus on its strengths and drive future growth in a dynamic and competitive environment. More widely, it reflects our commitment to enabling the segment to become the leading global player in microbial control."

Sven Abend, Executive Vice President and COO of the LSI segment, commented, "The carve-out represents a significant opportunity for LSI. It will enhance our performance levels by improving efficiency, creating synergies and delivering an improved customer value proposition. The carve-out will also deliver greater levels of transparency and control, which will give us the opportunity to shape our future and drive our success."

To further improve business efficiency, Lonza has also announced plans to enter consultations to make around 130 roles redundant, of which around 50 roles will be in Switzerland and 35 will be in the United States. Lonza is working to minimize job losses by transferring impacted employees to vacant positions and offering early retirements where appropriate. This program is limited to the LSI segment and the support functions and does not impact the Pharma Biotech & Nutrition (LPBN) segment.




Provider
Channel
Contact
Tensid EQS Ltd., Switzerland
www.tensid.ch


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
marco@tensid.ch
+41 41 763 00 50
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LONZA GROUP
07/11LONZA : Showcases Innovative Solutions to Make More Possible at the 14th Interna..
AQ
07/02LONZA : to Acquire Sterile Fill and Finish Facility from Novartis
AQ
07/01LONZA : Announces Short, Routine Shutdown of Niacinamide Plant in Nansha for Mai..
AQ
07/01Lonza fills portfolio hole by buying Novartis drug bottling plant
RE
06/26LONZA : Launches the First in a Series of Educational Videos on 'Keeping Our Wor..
AQ
06/20Lonza Publishes Restated Financials for 2018
TE
06/19LONZA : Invites Visitors to Make More Possible at Hi-Fi Asia-China 2019 with Sci..
AQ
06/11LONZA : Engine Equipment Portfolio Launched for Small Molecule Formulation and D..
AQ
06/06LONZA : to Host New Webinar Titled 'Know Your Enemy Mycoplasma Contamination in ..
AQ
06/03Carve-out of Lonza Specialty Ingredients will help segment to become a global..
TE
More news
Financials (CHF)
Sales 2019 5 909 M
EBIT 2019 1 215 M
Net income 2019 780 M
Debt 2019 3 100 M
Yield 2019 0,84%
P/E ratio 2019 32,4x
P/E ratio 2020 27,9x
EV / Sales2019 4,76x
EV / Sales2020 4,38x
Capitalization 25 021 M
Chart LONZA GROUP
Duration : Period :
Lonza Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 336,25  CHF
Last Close Price 337,00  CHF
Spread / Highest target 19,4%
Spread / Average Target -0,22%
Spread / Lowest Target -37,7%
EPS Revisions
Managers
NameTitle
Richard Ridinger Chief Executive Officer
Albert M. Baehny Chairman
Rodolfo Savitzky Chief Financial Officer
Patrick Aebischer Vice Chairman
Margot A. Scheltema Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LONZA GROUP32.31%25 111
IQVIA HOLDINGS INC34.78%31 409
CELLTRION, INC.--.--%20 827
INCYTE CORPORATION25.62%17 419
EXACT SCIENCES CORPORATION82.17%15 001
SEATTLE GENETICS, INC.11.39%10 516